CisplatinGrade I myelosuppression: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2044卷 / 1期

关键词：

D O I：

10.1007/s40278-025-75763-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：97 / 97

相关论文

共 50 条

[21] MethotrexateFebrile neutropenia and myelosuppression: case report
Reactions Weekly, 2021, 1846 (1) : 197 - 197
[22] AntineoplasticsTreatment failure and myelosuppression: case report
Reactions Weekly, 2023, 1952 (1) : 79 - 79
[23] AntineoplasticsLung injury and myelosuppression: case report
Reactions Weekly, 2022, 1926 (1) : 67 - 67
[24] Methotrexate/rituximabSevere myelosuppression: case report
Reactions Weekly, 2018, 1715 (1) : 177 - 177
[25] AntineoplasticsPeripheral neuropathy and myelosuppression: case report
Reactions Weekly, 2020, 1809 (1) : 41 - 41
[26] MitomycinInterstitial pneumonitis and myelosuppression: case report
Reactions Weekly, 2019, 1747 (1) : 184 - 184
[27] AntineoplasticsSevere hypoproliferation and myelosuppression: case report
Reactions Weekly, 2023, 1955 (1) : 49 - 49
[28] Multiple drugsThrombocytopenia and myelosuppression: case report
Reactions Weekly, 2025, 2054 (1) : 326 - 326
[29] Cisplatin/fluorouracilFatigue and myelosuppression: case report
Reactions Weekly, 2015, 1573 (1) : 70 - 70
[30] AntineoplasticsGastrointestinal disorders and myelosuppression: case report
Reactions Weekly, 2020, 1801 (1) : 33 - 33

← 1 2 3 4 5 →